|
|||||
A study will soon get underway with artificial intelligence and simulation analyzing data from clinical trials to identify factors behind responses to a treatment for colorectal cancer. . . . → Read More: A.I. to Identify Treatment Drivers for Colorectal Cancer 
An early-stage clinical trial is underway to test a treatment for Lassa fever, a viral disease found in West Africa, infecting as many as 300,000 individuals a year. . . . → Read More: Clinical Trial Underway for Lassa Fever Treatment  Comments are closed  New products  Africa, biomedical, biotechnology, clinical trials, FDA, life sciences, pharmaceuticals 
An engineering lab developed a technique to load molecules from white blood cells into tiny particles that act like sponges to reduce joint damage in lab mice from rheumatoid arthritis. . . . → Read More: Nanoscale Sponges Deliver Rheumatoid Arthritis Treatment Comments are closed New products biomedical, engineering, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, preclinical, university 
FDA plans to pilot test new types of complex clinical trials and is considering a procedure to evaluate machine learning algorithms used in diagnostics. . . . → Read More: FDA to Test New Trial Designs, Assess A.I. Models Comments are closed Regulations biomedical, clinical trials, engineering, FDA, genomics, life sciences, mathematics, medical device, pharmaceuticals, software 
A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers. . . . → Read More: Genentech Gains Modular Engineered Antibodies in $5B Deal Comments are closed Joint ventures/collaborations biomedical, biotechnology, cancer, Europe, licensing, life sciences, pharmaceuticals 
Researchers in France developed a system for computing data from CT scans and genomic analysis to predict the success for therapies that invoke the immune system in patients with solid-tumor cancers. . . . → Read More: A.I., Imaging Shown to Predict Immunotherapy Success 3 comments - (Comments are closed) New products biomedical, cancer, clinical trials, engineering, entrepreneurs, Europe, genomics, life sciences, mathematics, medical device, pharmaceuticals, physical sciences, university 
M.D. Anderson Cancer Center and a spin-off enterprise formed earlier this month are receiving nearly $50 million in grants from Texas’s state cancer prevention and research agency. . . . → Read More: M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency Comments are closed Finance biomedical, biotechnology, cancer, entrepreneurs, grant, life sciences, pharmaceuticals, university 
Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types. . . . → Read More: Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies 2 comments - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences 
A compound designed to help cancer therapies better penetrate and kill solid tumors is being tested in its first clinical trial among patients with pancreatic cancer. . . . → Read More: Trial Testing Cancer Treatment Delivery Compound One comment - (Comments are closed) New products Australia, biomedical, biotechnology, cancer, clinical trials, entrepreneurs, life sciences, pharmaceuticals 
Researchers in Italy and the U.S. found a potential source of new antibiotics in derivatives of peptides used by the digestive process in the stomach. . . . → Read More: New Antibiotics Discovered in Stomach Peptides Comments are closed New products biomedical, biotechnology, engineering, Europe, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
